The invention relates to ACE2 activating compounds for prevention and treatment of cardiovascular disease, kidney disease, lung disease and hypertension. The invention also includes methods of diagnosing cardiovascular disease, kidney disease, lung disease and hypertension by measuring ACE2 expression or nucleotide polymorphism analysis.

 
Web www.patentalert.com

< Investment and method for hedging operational risk associated with business events of another

< Devices, systems and methods for conditional instructions

> Automatic configuration of a microprocessor influenced by an input program

> Mice lacking alpha 1G showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1G T-type calcium channels
~ 00219